| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 16,445 | 16,003 | 14,721 | | Cost of Revenue | 5,769 | 4,201 | 8,670 | | | Gross Profit | 10,676 | 11,802 | 6,051 | | | Operating Expenses | | Research Development | 4,218 | 5,045 | 7,358 | | Selling General and Administrative | 11,829 | 12,091 | 17,268 | | Non Recurring | 805 | 21,064 | 6,005 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (6,176) | (26,398) | (24,580) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,089) | 2,858 | 3,742 | | Earnings Before Interest And Taxes | (8,265) | (23,539) | (20,838) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (8,265) | (23,539) | (20,838) | | Income Tax Expense | 157 | 361 | 106 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,422) | (23,901) | (20,944) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (8,422) | (23,901) | (20,944) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,422) | ($23,901) | ($20,944) |
|
1.48% Nasdaq 
0.001 (0.42%) 
Income Statement
